COVID-19 Articles
EADV is closely monitoring the ongoing coronavirus pandemic. As the situation continues to change rapidly, our top priority remains the health, safety, and well-being of our community.
We will continue to share knowledge and information through our channels.
General
Pitfalls of possible reporting of same patients with COVID-19 in various dermatology journals
Kluger N.
J Eur Acad Dermatol Venereol. 2020 Jun 3. doi: 10.1111/jdv.16690
SARS-CoV, Mers-CoV and Covid-19: : what differences from a dermatological viewpoint?
Rongioletti F.
J Eur Acad Dermatol Venereol. 2020 Jun 11. doi: 10.1111/jdv.16738
Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes on quality of life issues in dermatologic patients during the COVID-19 pandemic
Chernyshov PV, Tomas-Aragones L, Augustin M, Svensson A, Bewley A, Poot F, Szepietowski JC, Marron SE, Manolache L, Pustisek N, Suru A, Salavastru CM, Blome C, Salek MS, Abeni D, Sampogna F, Dalgard F, Linder D, Ewers A, Finlay AY.
J Eur Acad Dermatol Venereol. 2020 Jun 4. doi: 10.1111/jdv.16720
Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men
Goren A, Wambier CG, Herrera S, McCoy J, Vaño-Galván S, Gioia F, Comeche B, Ron R, Serrano-Villar S, Ramos PM, Cadegiani FA, Kovacevic M, Tosti A, Shapiro J, Sinclair R.
J Eur Acad Dermatol Venereol. 2020 Sep 25. doi: 10.1111/jdv.16953.
Androgen Receptor Genetic Variant Predicts COVID-19 Disease Severity: A Prospective Longitudinal Study of Hospitalized COVID-19 Male Patients
McCoy J, Wambier CG, Herrera S, Vaño-Galván S, Gioia F, Comeche B, Ron R, Serrano-Villar S, Iwasiow RM, Tayeb MA, Cadegiani FA, Mesinkovska NA, Shapiro J, Sinclair R, Goren A.
J Eur Acad Dermatol Venereol. 2020 Sep 25. doi: 10.1111/jdv.16956
SARS-CoV-2 spike protein in a chilblain-like skin lesion is present in both endothelial and eccrine cells
T. Gambichler, J. Reuther, M. Stücker, R. Stranzenbach, C. Torres‐Reyes, R. Schlottmann, W.E. Schmidt, R. Hayajneh, A. Sriram, J.C. Becker
J Eur Acad Dermatol Venereol. 2020 Sep 25. doi.org/10.1111/jdv.16970
Cross-country comparisons of Google searches for chilblains before and during the COVID-19 pandemic
Not all that glitters is COVID-19: a case-series demonstrating the need for histopathology when skin findings accompany SARS-CoV-2 infection
A Barrera-Godínez, S Méndez-Flores, M Gatica-Torres, A Rosales-Sotomayor, KI Campos-Jiménez, DM Carrillo-Córdova, MC Durand-Muñoz, GL Mena-Hernández, YK Melchor-Mendoza, AL Ruelas-Villavicencio, A García-Irigoyen, GA Acatitla-Acevedo, S Toussaint-Caire, J Domínguez-Cherit
J Eur Acad Dermatol Venereol. 2021 May 20 com/doi/10.1111/jdv.17381
SARS-CoV-2: skin diseases, mask wearing and unpleasant sensations
B Cribier, C Taieb, M Saint Aroman, J Shourick
J Eur Acad Dermatol Venereol. 2021 May 20 com/doi/10.1111/jdv.17380
Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional study
SK Mahil, M Yates, ZZN Yiu, SM Langan, T Tsakok, N Dand, KJ Mason, H McAteer, F Meynell, B Coker, A Vincent, D Urmston, A Vesty, J Kelly, C Lancelot, L Moorhead, H Bachelez, F Capon, CR Contreras, C De La Cruz, P Di Meglio, P Gisondi, D Jullien, J Lambert, L Naldi, S Norton, L Puig, P Spuls, T Torres, RB Warren, H Waweru, J Weinman, MA Brown, JB Galloway, CM Griffiths, JN Barker, CH Smith, On behalf of the PsoProtect study group
J Eur Acad Dermatol Venereol. 2021 Jun 17 com/doi/10.1111/jdv.17450
Changes in the incidence of contagious infectious skin diseases after the COVID-19 outbreak
E.J. Chun, J.K. Kim, S.Y. Yang, S.S. Kim, C.W. Kim
J Eur Acad Dermatol Venereol. 2021 Sep 6 com/doi/10.1111/jdv.17640
Estimating the incidence of Cutaneous COVID-19 reactions on the general population in a territorial setting
C. Zengarini, A. Guglielmo, M. Giovani, C. Preci, E. Dika, B.M. Piraccini, A. Pileri
J Eur Acad Dermatol Venereol. 2022 Jan 26 doi.org/10.1111/jdv.17970
Prevalence and patterns of cutaneous manifestations in 1245 COVID-19 patients in Japan: a single-centre study
T. Sugai, Y. Fujita, E. Inamura, Y. Maya, S. Shimizu
J Eur Acad Dermatol Venereol. 2022 Mar 11 doi.org/10.1111/jdv.18062
Ultrastructural evidence for anagen hair follicle infection with SARS-CoV-2 in early-onset COVID-19 effluvium
I.F.S. Mazeto,C.C. Brommonschenkel,A.C. Miola,P. Müller Ramos,D. Carvalho dos Santos,H.A. Miot
J Eur Acad Dermatol Venereol. 2022 June 20 doi.org/10.1111/jdv.16690
A spectrum of leprosy reactions triggered by Covid-19 vaccination: a series of four cases
N. Saraswat,D. M. Tripathy,S. Kumar,P. Awasthi,M. M. Gopal
J Eur Acad Dermatol Venereol. 2022 June 29 doi.org/10.1111/jdv.16738
L. Potestio,L. Genco,A. Villani,C. Marasca,G. Fabbrocini,L. Fornaro,A. Ruggiero,F. Martora
J Eur Acad Dermatol Venereol. 2022 June 20 doi.org/10.1111/jdv.16720
Face mask-induced purpura: another unexpected effect of COVID era
V. Piccolo,A. Bassi,C. Mazzatenta,T. Russo,G. Argenziano,M. Cutrone,Markus ES Danielsson Darlington,R. Grimalt
J Eur Acad Dermatol Venereol. 2022 June 30 doi.org/10.1111/jdv.18392
Effects of COVID-19 pandemic on malignant melanoma diagnosis
Alessia Villani,Massimiliano Scalvenzi,Gabriella Fabbrocini,Luigi Fornaro,Gianluca Guerrasio,Luca Potestio
J Eur Acad Dermatol Venereol. 2022 August 22 doi.org/10.1111/jdv.18545
Despite the use of ivermectin during the COVID pandemic, scabies keeps playing tricks with us
Juliana Polizel Ocanha-Xavier,José Cândido Caldeira Xavier-Junior
J Eur Acad Dermatol Venereol. 2022 August 22 doi.org/10.1111/jdv.18547
Cutaneous manifestations of COVID-19
Guidelines and recommendations
European Task Force on Atopic Dermatitis (ETFAD) statement on severe acute respiratory syndrome coronavirus 2 (SARS‐Cov‐2)‐infection and atopic dermatitisWollenberg A, Flohr C, Simon D, Cork MJ, Thyssen JP, Bieber T, de Bruin-Weller MS, Weidinger S, Deleuran M, Taieb A, Paul C, Trzeciak M, Werfel T, Seneschal J, Barbarot S, Darsow U, Torrelo A, Stalder JF, Svensson Å, Hijnen D, Gelmetti C, Szalai Z, Gieler U, De Raeve L, Kunz B, Spuls P, von Kobyletzki LB, Fölster-Holst R, Chernyshov PV, Cristen-Zaech S, Heratizadeh A, Ring J, Vestergaard C
J Eur Acad Dermatol Venereol. 2020 Mar 29. doi: 10.1111/jdv.16411
European Task Force on Contact Dermatitis statement on coronavirus 19 disease (COVID-19) outbreak and the risk of adverse cutaneous reactionsBalato A, Ayala F, Bruze M, Crepy MN, Gonçalo M, Duus Johansen J, John SM, Pigatto P, Raimondo A, Rustemeyer T, Schuttelaar MA, Svedman C, Aerst O, Uter W, Wilkinson M, Gimenez-Arnau A.
J Eur Acad Dermatol Venereol. 2020 Apr 30. doi: 10.1111/jdv.16557
Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemicKasperkiewicz M, Schmidt E, Fairley JA, Joly P, Payne AS, Yale ML, Zillikens D, Woodley DT
J Eur Acad Dermatol Venereol. 2020 Apr 25. doi: 10.1111/jdv.16525
Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines
Papadavid E, Scaribrick J, Ortiz Romero P, Guaglino P, Vermeer M, Knobler R, Stadler R, Bagot M.
J Eur Acad Dermatol Venereol. 2020 May 16. doi: 10.1111/jdv.16593
European Task Force on Atopic Dermatitis: position on vaccination of adult patients with atopic dermatitis against COVID‐19 (SARS‐CoV‐2) being treated with systemic medication and biologicsJ.P. Thyssen C. Vestergaard S. Barbarot M.S. de Bruin‐Weller T. Bieber A. Taieb J. Seneschal M.J. Cork C. Paul C. Flohr S. Weidinger M. Trzeciak T. Werfel A. Heratizadeh U. Darsow D. Simon A. Torrelo P.V. Chernyshov J.‐F. Stalder C. Gelmetti Z. Szalai Å. Svensson L.B. von Kobyletzki L. De Raeve R. Fölster‐Holst S. Christen‐Zaech D.J. Hijnen U. Gieler J. Gutermuth C. Bangert P.I. Spuls B. Kunz J. Ring A. Wollenberg M. Deleuran
J Eur Acad Dermatol Venereol. 2021 Feb 15 doi.org/10.1111/jdv.17167
Updated international expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemicM. Kasperkiewicz, E. Schmidt, M. Amagai, J.A. Fairley, P. Joly, D.F. Murrell, A.S. Payne, M.L. Yale, D. Zillikens, D.T. Woodley
J Eur Acad Dermatol Venereol. 2021 Mar 2 doi.org/10.1111/jdv.17207
Position statement of the EADV Melanoma Task Force on recommendations for the management of cutaneous melanoma patients during COVID-19M. Arenbergerova, A. Lallas, E. Nagore, L. Rudnicka, A. Forsea, M. Pasek, F. Meier, K. Peris, J. Olah, C. Posch
J Eur Acad Dermatol Venereol. 2021 Mar 29 doi.org/10.1111/jdv.17252
Biologics and immunomodulatory therapies
Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases?Di Altobrando A, Patrizi A, Bardazzi F.
J Eur Acad Dermatol Venereol. 2020 Apr 17. doi: 10.1111/jdv.16491
SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor
Messina F, Piaserico S.
J Eur Acad Dermatol Venereol. 2020 Apr 15. doi: 10.1111/jdv.16468
Safety of dupilumab in severe atopic dermatitis and infection of Covid-19: two case reports
Ferrucci S, Romagnuolo M, Angileri L, Berti E, Tavecchio S.
J Eur Acad Dermatol Venereol. 2020 Apr 24. doi: 10.1111/jdv.16527
No evidence of increased risk for COVID-19 infection in patients treated with Dupilumab for atopic dermatitis in a high-epidemic area – Bergamo, Lombardy, ItalyCarugno A, Raponi F, Locatelli AG, Vezzoli P, Gambini DM, Di Mercurio M, Robustelli Test E, Sena P.
J Eur Acad Dermatol Venereol. 2020 Apr 27. doi: 10.1111/jdv.16552
“Toxic Erythema” and Eosinophilia Associated to Tocilizumab Therapy in a COVID-19 PatientSernicola A, Carnicelli G, Di Fraia M, Chello C, Furlan C, Muharremi R, Paolino G, Grieco T.
J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16620
Evolution of COVID-19 infection in 4 psoriatic patients treated with biological drugsConti A, Lasagni C, Bigi L, Pellacani G.
J Eur Acad Dermatol Venereol. 2020 May 7. doi: 10.1111/jdv.16587
Improvement of SARS-CoV2 symptoms following guselkumab injection in a psoriatic patientBenhadou F, Del Marmol V.
J Eur Acad Dermatol Venereol. 2020 May 7. doi: 10.1111/jdv.16590
SARS-CoV-2 asymptomatic infection in a patient under treatment with dupilumab
Caroppo F, Biolo G, Belloni Fortina A.
J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16619
SARS-CoV-2 infection in a psoriatic patient treated with IL-17 inhibitorBalestri R, Rech G, Girardelli CR
J Eur Acad Dermatol Venereol. 2020 May 2. doi: 10.1111/jdv.16571
Prior treatment with immunosuppressants among COVID-19 inpatients in one hospital in SpainPastor-Nieto MA, Checa-Díaz P, González-Muñoz P, Martín-Fuentes A, Vergara-Sánchez A, Sánchez-Herreros C, Jiménez-Blázquez E, Cabana-Navia R, Martínez-Mariscal J, Cobo-Rodríguez P, Checa-Recio I, Gatica-Ortega ME, Torralba M, De Eusebio-Murillo E
J Eur Acad Dermatol Venereol. 2020 Jun 28. doi.org/10.1111/jdv.16798
Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID-19Fougerousse AC, Perrussel M, Bécherel PA, Begon E, Pallure V, Zaraa I, Chaby G, Parier J, Kemula M, Mery-Bossard L, Poreaux C, Taieb C, Maccari F, Reguiai Z; GEM Resopso
J Eur Acad Dermatol Venereol. 2020 Jun 21. doi: 10.1111/jdv.16761
Compliance, safety concerns and anxiety in patients treated with biologics for psoriasis during the COVID-19 pandemic national lockdown: A multicenter study in the Czech RepublicRob F, Hugo J, Tivadar S, Boháč P, Gkalpakiotis S, Vargová N, Arenbergerová M, Hercogová J.
J Eur Acad Dermatol Venereol. 2020 Jun 27. doi: 10.1111/jdv.16771
Toxic epidermal necrolysis and co-existent SARS-CoV-2 (COVID-19) treated with Intravenous Immunoglobulin: “Killing 2 birds with one stone”Saha M, D’Cruz A, Paul N, Healy R, Collins D, Charles DA, Sahu S, Fonia A.
J Eur Acad Dermatol Venereol. 2020 Aug 17. doi: 10.1111/jdv.16887
Position Statement for a Pragmatic Approach to Immunotherapeutics in Patients with Inflammatory Skin Diseases during the COVID-19 Pandemic and BeyondJ. Beecker K.A. Papp J. Dutz R.B. Vender R. Gniadecki C. Cooper P. Gisondi M. Gooderham C.H. Hong M.G. Kirchhof C.W. Lynde C. Maari Y. Poulin L. Puig
J Eur Acad Dermatol Venereol. 2021 Feb 3 doi.org/10.1111/jdv.17075
Understanding Views of Patients on Biologics for Psoriasis Amid the COVID-19 Pandemic
K. Pandher C.L. Porter H.S. Patel W.W. Huang S.R. Feldman
J Eur Acad Dermatol Venereol. 2020 Nov 17 doi.org/10.1111/jdv.17091
Good tolerance of hyaluronic acid injections during the Covid-19 pandemic period: a prospective observational real-life study of a cohort of 1093 patients with a 3 month-follow up periodMichael Naouri Serge Dahan Anne Le Pillouer Prost Phrynée Coutant‐Foulc Catherine Raimbault Françoise Cucurella Laurence Beille Muriel Creusot Martine Baspeyras Martine Darchy Randa Khallouf Hugues Cartier Isabelle Baratte Magali Dubois Olivier Cogrel Hans Laubach Groupe de Dermatologie Esthétique et Correctrice de la Société Française de Dermatologie (GDEC)
J Eur Acad Dermatol Venereol. 2021 Apr 8 doi.org/10.1111/jdv.17271
Autoantibodies in Covid19 – A model for viral induced autoimmunityJ. Berger, S. Volc
J Eur Acad Dermatol Venereol. 2021 May 25 com/doi/10.1111/jdv.17396
SARS-CoV-2 Serology In Patients On Biological Therapy or Apremilast For Psoriasis: A Study of 93 Patients in the Italian Red ZoneSyed M. A. Ahmed,Martina Volontè,Eugenio Isoletta,Camilla Vassallo,Carlo Francesco Tomasini,Daniele Lilleri,Paola Zelini,Valeria Musella,Catherine Klersy,Valeria Brazzelli
J Eur Acad Dermatol Venereol. 2021 Oct 4 doi.org/10.1111/jdv.17721
Clinical set-up and service delivery
Pitfalls of possible reporting of same patients with COVID-19 in various dermatology journals
Kluger N.
J Eur Acad Dermatol Venereol. 2020 Jun 3. doi: 10.1111/jdv.16690
SARS-CoV, Mers-CoV and Covid-19: : what differences from a dermatological viewpoint?
Rongioletti F.
J Eur Acad Dermatol Venereol. 2020 Jun 11. doi: 10.1111/jdv.16738
Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes on quality of life issues in dermatologic patients during the COVID-19 pandemic
Chernyshov PV, Tomas-Aragones L, Augustin M, Svensson A, Bewley A, Poot F, Szepietowski JC, Marron SE, Manolache L, Pustisek N, Suru A, Salavastru CM, Blome C, Salek MS, Abeni D, Sampogna F, Dalgard F, Linder D, Ewers A, Finlay AY.
J Eur Acad Dermatol Venereol. 2020 Jun 4. doi: 10.1111/jdv.16720
Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men
Goren A, Wambier CG, Herrera S, McCoy J, Vaño-Galván S, Gioia F, Comeche B, Ron R, Serrano-Villar S, Ramos PM, Cadegiani FA, Kovacevic M, Tosti A, Shapiro J, Sinclair R.
J Eur Acad Dermatol Venereol. 2020 Sep 25. doi: 10.1111/jdv.16953.
Androgen Receptor Genetic Variant Predicts COVID-19 Disease Severity: A Prospective Longitudinal Study of Hospitalized COVID-19 Male Patients
McCoy J, Wambier CG, Herrera S, Vaño-Galván S, Gioia F, Comeche B, Ron R, Serrano-Villar S, Iwasiow RM, Tayeb MA, Cadegiani FA, Mesinkovska NA, Shapiro J, Sinclair R, Goren A.
J Eur Acad Dermatol Venereol. 2020 Sep 25. doi: 10.1111/jdv.16956
SARS-CoV-2 spike protein in a chilblain-like skin lesion is present in both endothelial and eccrine cells
T. Gambichler, J. Reuther, M. Stücker, R. Stranzenbach, C. Torres‐Reyes, R. Schlottmann, W.E. Schmidt, R. Hayajneh, A. Sriram, J.C. Becker
J Eur Acad Dermatol Venereol. 2020 Sep 25. doi.org/10.1111/jdv.16970
Cross-country comparisons of Google searches for chilblains before and during the COVID-19 pandemic
Not all that glitters is COVID-19: a case-series demonstrating the need for histopathology when skin findings accompany SARS-CoV-2 infection
A Barrera-Godínez, S Méndez-Flores, M Gatica-Torres, A Rosales-Sotomayor, KI Campos-Jiménez, DM Carrillo-Córdova, MC Durand-Muñoz, GL Mena-Hernández, YK Melchor-Mendoza, AL Ruelas-Villavicencio, A García-Irigoyen, GA Acatitla-Acevedo, S Toussaint-Caire, J Domínguez-Cherit
J Eur Acad Dermatol Venereol. 2021 May 20 com/doi/10.1111/jdv.17381
SARS-CoV-2: skin diseases, mask wearing and unpleasant sensations
B Cribier, C Taieb, M Saint Aroman, J Shourick
J Eur Acad Dermatol Venereol. 2021 May 20 com/doi/10.1111/jdv.17380
Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional study
SK Mahil, M Yates, ZZN Yiu, SM Langan, T Tsakok, N Dand, KJ Mason, H McAteer, F Meynell, B Coker, A Vincent, D Urmston, A Vesty, J Kelly, C Lancelot, L Moorhead, H Bachelez, F Capon, CR Contreras, C De La Cruz, P Di Meglio, P Gisondi, D Jullien, J Lambert, L Naldi, S Norton, L Puig, P Spuls, T Torres, RB Warren, H Waweru, J Weinman, MA Brown, JB Galloway, CM Griffiths, JN Barker, CH Smith, On behalf of the PsoProtect study group
J Eur Acad Dermatol Venereol. 2021 Jun 17 com/doi/10.1111/jdv.17450
Changes in the incidence of contagious infectious skin diseases after the COVID-19 outbreak
E.J. Chun, J.K. Kim, S.Y. Yang, S.S. Kim, C.W. Kim
J Eur Acad Dermatol Venereol. 2021 Sep 6 com/doi/10.1111/jdv.17640
Estimating the incidence of Cutaneous COVID-19 reactions on the general population in a territorial setting
C. Zengarini, A. Guglielmo, M. Giovani, C. Preci, E. Dika, B.M. Piraccini, A. Pileri
J Eur Acad Dermatol Venereol. 2022 Jan 26 doi.org/10.1111/jdv.17970
Prevalence and patterns of cutaneous manifestations in 1245 COVID-19 patients in Japan: a single-centre study
T. Sugai, Y. Fujita, E. Inamura, Y. Maya, S. Shimizu
J Eur Acad Dermatol Venereol. 2022 Mar 11 doi.org/10.1111/jdv.18062
Ultrastructural evidence for anagen hair follicle infection with SARS-CoV-2 in early-onset COVID-19 effluvium
I.F.S. Mazeto,C.C. Brommonschenkel,A.C. Miola,P. Müller Ramos,D. Carvalho dos Santos,H.A. Miot
J Eur Acad Dermatol Venereol. 2022 June 20 doi.org/10.1111/jdv.16690
A spectrum of leprosy reactions triggered by Covid-19 vaccination: a series of four cases
N. Saraswat,D. M. Tripathy,S. Kumar,P. Awasthi,M. M. Gopal
J Eur Acad Dermatol Venereol. 2022 June 29 doi.org/10.1111/jdv.16738
L. Potestio,L. Genco,A. Villani,C. Marasca,G. Fabbrocini,L. Fornaro,A. Ruggiero,F. Martora
J Eur Acad Dermatol Venereol. 2022 June 20 doi.org/10.1111/jdv.16720
Face mask-induced purpura: another unexpected effect of COVID era
V. Piccolo,A. Bassi,C. Mazzatenta,T. Russo,G. Argenziano,M. Cutrone,Markus ES Danielsson Darlington,R. Grimalt
J Eur Acad Dermatol Venereol. 2022 June 30 doi.org/10.1111/jdv.18392
Effects of COVID-19 pandemic on malignant melanoma diagnosis
Alessia Villani,Massimiliano Scalvenzi,Gabriella Fabbrocini,Luigi Fornaro,Gianluca Guerrasio,Luca Potestio
J Eur Acad Dermatol Venereol. 2022 August 22 doi.org/10.1111/jdv.18545
Despite the use of ivermectin during the COVID pandemic, scabies keeps playing tricks with us
Juliana Polizel Ocanha-Xavier,José Cândido Caldeira Xavier-Junior
J Eur Acad Dermatol Venereol. 2022 August 22 doi.org/10.1111/jdv.18547
Coronavirus aetiology, severity and transmission
5-Alpha-Reductase Inhibitors are Associated with Reduced Frequency of COVID-19 Symptoms in Males with Androgenetic AlopeciaJ. McCoy F.A. Cadegiani C.G. Wambier S. Herrera S. Vaño‐Galván N.A. Mesinkovska P.M. Ramos J. Shapiro R. Sinclair A. Tosti A. Goren
J Eur Acad Dermatol Venereol. 2020 Nov 2 doi.org/10.1111/jdv.17021
Extraordinary claims without extraordinary evidence Controversy on Anti-Androgen Therapy for COVID-19R.M. Trüeb A. Régnier N. Caballero‐Uribe M.F. Reis Gavazzoni Dias H. Dutra Rezende
J Eur Acad Dermatol Venereol. 2021 Mar 30 doi.org/10.1111/jdv.17249
Prevalence and characteristics of dermatological manifestations in COVID-19 positive dermatologists: Report from a web-based survey in IndiaDeepak Jakhar, Anupam Das, Subuhi Kaul, Ishmeet Kaur, Bhushan Madke, Ashish Dalal
J Eur Acad Dermatol Venereol. 2021 Jul 23 com/doi/10.1111/jdv.17532
Late-onset pustular skin eruption in a healthy neonate born from COVID-positive mother: a coincidence or a new skin sign of the infection?V. Piccolo, C. Mazzatenta, T. Russo, F. Morandi, A. Bassi, G. Argenziano, E. Valerio, R. Grimalt, M. Cutrone
J Eur Acad Dermatol Venereol. 2021 Aug 7 doi/abs/10.1111/jdv.17579
Raquel Falcão de Freitas, António Freitas
J Eur Acad Dermatol Venereol. 23 August 2023 doi.org/10.1111/jdv.19459
Coronavirus drugs
Prompt onset of erythema multiforme following the first BNT162b2 SARS-CoV-2 vaccinationT. Gambichler L. Scholl L. Ocker R. Stranzenbach
J Eur Acad Dermatol Venereol. 2021 Mar 16 doi.org/10.1111/jdv.17225
Lichen planus arising after COVID-19 vaccination
I. Hiltun J. Sarriugarte I. Martínez‐de‐Espronceda A. Garcés C. Llanos R. Vives J.I. Yanguas
J Eur Acad Dermatol Venereol. 2021 Mar 16 doi.org/10.1111/jdv.17221
Persistent maculopapular rash after the first dose of Pfizer-BioNTech COVID-19 vaccine
M. Ackerman D. Henry A. Finon R. Binois E. Esteve
J Eur Acad Dermatol Venereol. 2021 Mar 30 doi.org/10.1111/jdv.17248
Skin manifestations of the BNT162b2 mRNA COVID-19 vaccine in healthcare workers. “COVID-arm”: a clinical and histological characterizationD. Fernandez‐Nieto J. Hammerle M. Fernandez‐Escribano CM Moreno‐del Real P. Garcia‐Abellas I. Carretero‐Barrio E. Solano‐Solares B de‐la‐Hoz‐Caballer J. Jimenez‐Cauhe D. Ortega‐Quijano M. Fernandez‐Guarino
J Eur Acad Dermatol Venereol. 2021 Mar 30 doi.org/10.1111/jdv.17250
Pityriasis rosea following CoronaVac COVID-19 vaccination: a case reportE. Akdaş N. İlter B. Öğüt Ö. Erdem
J Eur Acad Dermatol Venereol. 2021 Apr 29 com/doi/10.1111/jdv.17316
BNT162b2 mRNA Covid-19 Vaccine-induced chilblain-like lesions reinforces the hypothesis of their relationship with SARS-CoV-2
V. Piccolo, A. Bassi, G. Argenziano, C. Mazzatenta, M. Cutrone, I. Neri, R. Grimalt, T. Russo
J Eur Acad Dermatol Venereol. 2021 Apr 29 com/doi/10.1111/jdv.17320
Anaphylaxis to vaccination and polyethylene glycol (PEG): A perspective from the European Anaphylaxis RegistryM Kraft, JM Renaudin, LF Ensina, A Kleinheinz, MB Bilò, K Scherer Hofmeier, S Dölle-Bierke, M Worm
J Eur Acad Dermatol Venereol. 2021 Apr 29 doi/abs/10.1111/jdv.17327
Cutaneous adverse reactions after m-RNA COVID-19 vaccine: early reports from North-East Italy
E. Farinazzo, G. Ponis, E. Zelin, E. Errichetti, G. Stinco, C. Pinzani, A. Gambelli, N. De Manzini, L. Toffoli, A. Moret, M. Agozzino, C. Conforti, N. Di Meo, P. Schincariol, I. Zalaudek
J Eur Acad Dermatol Venereol. 2021 May 22 doi/abs/10.1111/jdv.17343
Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine
Benoit Cyrenne, Faisal Al-Mohammedi, Joel DeKoven, Raed Alhusayen
J Eur Acad Dermatol Venereol. 2021 May 13 com/doi/10.1111/jdv.17342
Purpuric lesions on the eyelids developed after BNT162b2 mRNA Covid-19 Vaccine: another piece of SARS-CoV-2 skin puzzle?
C. Mazzatenta, V. Piccolo, G. Pace, I. Romano, G. Argenziano, A. Bassi
J Eur Acad Dermatol Venereol. 2021 May 28 oi/full/10.1111/jdv.17340
Ipsilateral Herpes Zoster after the first dose of BNT162b2 mRNA COVID-19 vaccineI. Tessas, N. Kluger
J Eur Acad Dermatol Venereol. 2021 May 31 oi/full/10.1111/jdv.17422
SARS-CoV-2 mRNA Vaccine-Associated Fixed Drug Eruption
Dillon Mintoff, David Pisani, Alexandra Betts, Lawrence Scerri
J Eur Acad Dermatol Venereol. 2021 May 25 com/doi/10.1111/jdv.17390
Immune thrombocytopenic purpura associated with COVID-19 Pfizer-BioNTech BNT16B2b2 mRNA vaccineP. K. Krajewski, J. C. Szepietowski
J Eur Acad Dermatol Venereol. 2021 Jun 2 com/doi/10.1111/jdv.17444
Chilblain-like lesions after BNT162b2 mRNA COVID-19 vaccine: a case report suggesting that ‘COVID toes’ are due to the immune reaction to SARS-CoV-2C. Lesort, J. Kanitakis, L. Donzier, D. Jullien
J Eur Acad Dermatol Venereol. 2021 Jun 16 com/doi/10.1111/jdv.17451
Systemic drug-related intertriginous and flexural exanthema like eruption after CoronaVac vaccineO.M. Orenay, I. Balta, D. Yigit, M. Eksioglu
J Eur Acad Dermatol Venereol. 2021 Jun 17 oi/10.1111/jdv.17454?af=R
Psoriasis flare up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccineP.K. Krajewski, Ł. Matusiak, J.C. Szepietowski
J Eur Acad Dermatol Venereol. 2021 Jun 16 com/doi/10.1111/jdv.17449
First dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose contraindicated?G. Damiani, A. Pacifico, F. Pelloni, M. Iorizzo
J Eur Acad Dermatol Venereol. 2021 Jun 25 com/doi/10.1111/jdv.17472
Delayed cutaneous reaction to ChAdOx1 nCoV-19 vaccine: Is it an ‘AstraZeneca arm’?J.E. Kim, H. Lee, S.S. Paik, J.-Y. Moon, H.J. Yoon, S.-H. Kim
J Eur Acad Dermatol Venereol. 2021 Jun 24 com/doi/10.1111/jdv.17476
Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2F. Solimani, Y. Mansour, D. Didona, A. Dilling, K. Ghoreschi, K. Meier
J Eur Acad Dermatol Venereol. 2021 Jun 25 com/doi/10.1111/jdv.17480
Pernio-like skin lesions after the second dose of Pfizer-BioNTech COVID-19 vaccineN. Cameli, M. Silvestri, M. Mariano, S.P. Nisticò, A. Cristaudo
J Eur Acad Dermatol Venereol. 2021 Jul 8 com/doi/10.1111/jdv.17500
Transition of cutaneous into systemic lupus erythematosus following adenoviral vector-based SARS-CoV-2 vaccinationA. Kreuter, S.-N. Burmann, B. Burkert, F. Oellig, A.-L. Michalowitz
J Eur Acad Dermatol Venereol. 2021 Jul 9 oi/full/10.1111/jdv.17514
Widespread purpura annularis telangiectodes following mRNA SARS-CoV-2 vaccineD. Falkenhain-López, C. Gutiérrez-Collar, J. Arroyo-Andrés, I. Gallego-Gutiérrez, J.L. Rodríguez-Peralto, A. Sánchez-Velázquez
J Eur Acad Dermatol Venereol. 2021 Jul 8 com/doi/10.1111/jdv.17497
‘COVID arm’ – histological features of a delayed-type hypersensitivity reaction to Moderna mRNA-1273 SARS-CoV2 vaccineW. Kempf, N. Kettelhack, F. Kind, S. Courvoisier, J. Galambos, K. Pfaltz
J Eur Acad Dermatol Venereol. 2021 Jul 9 oi/full/10.1111/jdv.17506
Erythema multiforme after CoronaVac vaccinationN.T. Lopes, C.E.O. Pinilla, A.C. Gerbase
J Eur Acad Dermatol Venereol. 2021 Jul 8 com/doi/10.1111/jdv.17495
New onset of remitting seronegative symmetrical synovitis with pitting oedema and palmoplantar psoriasis flare-up after Sars-Cov-2 vaccination
L. Quattrini, L. Verardi, G. Caldarola, G. Peluso, C. De Simone, M. D’Agostino
J Eur Acad Dermatol Venereol. 2021 Jul 8 com/doi/10.1111/jdv.17502
Generalized eczematous reactions to the Pfizer-BioNTech COVID-19 vaccine
A.C. Leasure, S.E. Cowper, J. McNiff, J.M. Cohen
J Eur Acad Dermatol Venereol. 2021 Jul 8 com/doi/10.1111/jdv.17494
New-onset cutaneous lichen planus triggered by COVID-19 vaccinationR. Merhy, A.-S. Sarkis, J. Kaikati, L. El Khoury, S. Ghosn, F. Stephan
J Eur Acad Dermatol Venereol. 2021 Jul 8 oi/full/10.1111/jdv.17504
Pityriasis rosea developing after COVID-19 vaccinationO.Y. Marcantonio-Santa Cruz, A. Vidal-Navarro, D. Pesqué, A.M. Giménez-Arnau, R.M. Pujol, G. Martin-Ezquerra
J Eur Acad Dermatol Venereol. 2021 Jul 8 com/doi/10.1111/jdv.17498
Herpes Zoster following SARS-CoV-2 vaccination – a series of four casesM. Alpalhão, P. Filipe
J Eur Acad Dermatol Venereol. 2021 Jul 26 com/doi/10.1111/jdv.17555
Small-vessel vasculitis following Oxford-AstraZeneca vaccination against SARS-CoV-2L. Guzmán-Pérez, M. Puerta-Peña, D. Falkenhain-López, J. Montero-Menárguez, C. Gutiérrez-Collar, J.L. Rodríguez-Peralto, J. Sanz-Bueno
J Eur Acad Dermatol Venereol. 2021 Jul 26 com/doi/10.1111/jdv.17547
New-onset acral lesions on hands after administration of mRNA-1273 vaccine against SARS-CoV-2: clinical images and histopathological study of three casesD. Revilla-Nebreda, M. Roncero-Riesco, Á. Santos-Briz, M. Medina-Migueláñez, N. Segurado-Tostón, C. Román-Curto
J Eur Acad Dermatol Venereol. 2021 Jul 26 oi/full/10.1111/jdv.17553
Small vessel vasculitis related to varicella-zoster virus after Pfizer-BioNTech COVID-19 vaccineF. Nastro, G. Fabbrocini, F. di Vico, C. Marasca
J Eur Acad Dermatol Venereol. 2021 Jul 26 com/doi/10.1111/jdv.17550
Omalizumab prevents anaphylactoid reactions to mRNA COVID-19 vaccineA. Smola, S. Samazadeh, L. Müller, O. Adams, B. Homey, P. Albrecht, S. Meller
J Eur Acad Dermatol Venereol. 2021 Jul 26 doi/abs/10.1111/jdv.17549
New onset of mainly guttate psoriasis after COVID-19 vaccination: a case reportM. Lehmann, P. Schorno, R.E. Hunger, K. Heidemeyer, L. Feldmeyer, N. Yawalkar
J Eur Acad Dermatol Venereol. 2021 Jul 26 com/doi/10.1111/jdv.17561
A skin reaction with rust-like discolouration to mRNA COVID-19 vaccineR. Pasternack, S. Pohjavaara
J Eur Acad Dermatol Venereol. 2021 Jul 26 oi/full/10.1111/jdv.17543
Pityriasis rubra pilaris after Vaxzevria® COVID-19 vaccine
Iñigo Lladó, Beatriz Butrón-Bris, Raquel Sampedro-Ruiz, Javier Fraga, Diego de Argila
J Eur Acad Dermatol Venereol. 2021 Jul 26 com/doi/10.1111/jdv.17542
Cutaneous reactions to inactivated SARS-CoV-2 vaccine and ChAdOx1-S (recombinant) vaccine against SARS-CoV-2: a case series from the PhilippinesJ.N. Yu, C.B. Angeles, H.G. Lim, C. Chavez, C. Roxas-Rosete
J Eur Acad Dermatol Venereol. 2021 Aug 7 oi/full/10.1111/jdv.17575
Herpes zoster after ChAdOx1 nCoV-19 vaccine: a case seriesM. Vastarella, V. Picone, F. Martora, G. Fabbrocini
J Eur Acad Dermatol Venereol. 2021 Aug 7 com/doi/10.1111/jdv.17576
Three cases of vesiculobullous non-IgE-mediated cutaneous reactions to tozinameran (Pfizer-BioNTech COVID-19 vaccine)L. Juay, N.S. Chandran
J Eur Acad Dermatol Venereol. 2021 Aug 7 com/doi/10.1111/jdv.17581
Cutaneous reactions following CoronaVac COVID-19 vaccination: a case series of six healthcare workers from a single centreE. Akdaş, B. Öğüt, Ö. Erdem, M.O. Öztaş, N. İlter
J Eur Acad Dermatol Venereol. 2021 Aug 9 oi/full/10.1111/jdv.17592
Rare cutaneous adverse effects of COVID-19 vaccines: a case series and review of the literatureE. Annabi,N. Dupin,P. Sohier,B. Garel,N. Franck,S. Aractingi,S. Guégan,B. Oulès
J Eur Acad Dermatol Venereol. 2021 Aug 7 doi.org/10.1111/jdv.17578
Herpes zoster after inactivated SARS-CoV-2 vaccine in two healthy young adults
A.K. Özdemir, S. Kayhan, S.K. Çakmak
J Eur Acad Dermatol Venereol. 2021 Aug 7 oi/full/10.1111/jdv.17577
Psoriasis exacerbation after COVID-19 vaccination: a report of 14 cases from a single centreE. Sotiriou, A. Tsentemeidou, K. Bakirtzi, A. Lallas, D. Ioannides, E. Vakirlis
J Eur Acad Dermatol Venereol. 2021 Aug 7 com/doi/10.1111/jdv.17582
Erythema gyratum repens after COVID-19R. Castro Silva, G. Castro Silva, M.C. Castro Silva, O. Lupi
J Eur Acad Dermatol Venereol. 2021 Aug 7 com/doi/10.1111/jdv.17583
A Bullous Eruption following the Pfizer-BioNTech COVID-19 vaccinationA. D’Cruz,H. Parker,M. Saha
J Eur Acad Dermatol Venereol. 2021 Aug 20 com/doi/10.1111/jdv.17606
Two cases of papulo-pustular rosacea-like eruptions following COVID-19 vaccinationsG. Ciccarese,F. Drago,A. Rebora,A. Parodi
J Eur Acad Dermatol Venereol. 2021 Aug 20 com/doi/10.1111/jdv.17615
‘COVID vaccine arm’ may present after both mRNA vaccines vaccinationS. Gregoriou,I. A. Kleidona,A. Tsimpidakis,E. Nicolaidou,A. Stratigos,D. Rigopoulos
J Eur Acad Dermatol Venereol. 2021 Aug 20 com/doi/10.1111/jdv.17614
Flagellate purpura associated with COVID-19 vaccinationE. Heck,B.D. Rankin,M. Schneider,V.H. Prajapati
J Eur Acad Dermatol Venereol. 2021 Aug 20 com/doi/10.1111/jdv.17609
Clinicopathological features of cutaneous reactions after mRNA-based COVID-19 vaccinesM. Tihy,S. Menzinger,R. André,E. Laffitte,L. Toutous-Trellu,G. Kaya
J Eur Acad Dermatol Venereol. 2021 Aug 30 com/doi/10.1111/jdv.17633
Two cases of pityriasis rosea after the injection of coronavirus disease 2019 vaccineL. Huang, Z. Yao, J. Zhang
J Eur Acad Dermatol Venereol. 2021 Sep 7 oi/full/10.1111/jdv.17648
Varicella Zoster and Herpes Simplex Virus Reactivation Post-COVID-19 Vaccination: A Review of 40 Cases in an International Dermatology RegistryRamie A. Fathy,Devon E. McMahon,Cynthia Lee,Grace C. Chamberlin,Misha Rosenbach,Jules B. Lipoff,Anisha Tyagi,Seemal R. Desai,Lars E. French,Henry W. Lim,Bruce H. Thiers,George J. Hruza,Marlys Fassett,Lindy P. Fox,Harry L. Greenberg,Kimberly Blumenthal,Esther E. Freeman
J Eur Acad Dermatol Venereol. 2021 Sep 6 com/doi/10.1111/jdv.17646
COVID vaccine-induced lichen planus on areas previously affected by vitiligoVincenzo Piccolo,Carlo Mazzatenta,Andrea Bassi,Giuseppe Argenziano,Mario Cutrone,Ramon Grimalt,Teresa Russo
J Eur Acad Dermatol Venereol. 2021 Sep 21 com/doi/10.1111/jdv.17687
Erythema multiforme after SARS-CoV-2 vaccineLi-wen Zhang,Wen-ju Wang,Cong-hui Li,Tao Chen
J Eur Acad Dermatol Venereol. 2021 Sep 21 com/doi/10.1111/jdv.17689
New-onset and exacerbations of psoriasis after mRNA COVID-19 vaccines: two sides of the same coin?David Pesqué,Emilio Lopez-Trujillo,Orianna Marcantonio,Ana Maria Giménez-Arnau,Ramon Maria Pujol
J Eur Acad Dermatol Venereol. 2021 Sep 21 com/doi/10.1111/jdv.17690
Eosinophilic cellulitis after BNT162b2 mRNA Covid-19 vaccineLaurence de Montjoye,Liliane Marot,Marie Baeck
J Eur Acad Dermatol Venereol. 2021 Sep 21 com/doi/10.1111/jdv.17685
Pfizer-BioNTech SARS-CoV-2 mRNA Vaccine-associated Erythema MultiformeLuca Borg,Liam Mercieca,Dillon Mintoff,Daniel Micallef,David Pisani,Alexandra Betts,Lawrence Scerri
J Eur Acad Dermatol Venereol. 2021 Sep 21 com/doi/10.1111/jdv.17682
Erythema nodosum, zoster duplex and pityriasis rosea as possible cutaneous adverse effects of Oxford–AstraZeneca COVID-19 vaccine: report of three cases from IndiaHitaishi Mehta,Sanjeev Handa,Pankaj Malhotra,Meenakshi Patial,Smriti Gupta,Anirudh Mukherjee,Debajyoti Chatterjee,Aastha Takkar,Rahul Mahajan
J Eur Acad Dermatol Venereol. 2021 Sep 21 doi/abs/10.1111/jdv.17678
Early atypical injection-site reactions to COVID-19 vaccine: a case seriesM. Vaccaro,L. Bertino,R. Squeri,C. Genovese,S. Isola,G. Spatari,E. Spina,P. Cutroneo
J Eur Acad Dermatol Venereol. 2021 Sep 21 com/doi/10.1111/jdv.17683
Nevocentric erythema multiforme after SARS-COV-2 VaccineC. Scharf,E. V. di Brizzi,S. Pellerone,M. Liguori,C.M.R. Giorgio,G. Argenziano
J Eur Acad Dermatol Venereol. 2021 Sep 21 com/doi/10.1111/jdv.17688
SARS-CoV-2 mRNA Vaccine Injection Site PseudolymphomaDillon Mintoff,Lawrence Scerri,Alexandra Betts
J Eur Acad Dermatol Venereol. 2021 Sep 21 oi/10.1111/jdv.17680?af=R
A case of bullous pemphigoid after the SARS-CoV-2 mRNA vaccineJ. Young,L. Mercieca,M. Ceci,D. Pisani,A. Betts,M.J. Boffa
J Eur Acad Dermatol Venereol. 2021 Sep 21 com/doi/10.1111/jdv.17676
Recurrence of Cutaneous T-cell lymphoma (CTCL) post viral vector COVID-19 vaccinationE Panou,V Nikolaou,L Marinos,S Kallambou,P Sidiropoulou,M Gerochristou,A Stratigos
J Eur Acad Dermatol Venereol. 2021 Oct 10 doi.org/10.1111/jdv.17736
Development of oral lichen planus after COVID-19 vaccination – a rare case reportP. Sharda, A. Mohta, B.C. Ghiya, R.D. Mehta
J Eur Acad Dermatol Venereol. 2021 Oct 4 oi/full/10.1111/jdv.17718
Eruptive angiomatosis after SARS-CoV-2 Vaccine (Comirnaty, Pfizer)Corrado Zengarini,Cosimo Misciali,Tiziana Lazzarotto,Emi Dika
J Eur Acad Dermatol Venereol. 2021 Oct 4 doi.org/10.1111/jdv.17723
Biphasic bullous pemphigoid starting after first dose and boosted by second dose of mRNA-1273 vaccine in an 84-year-old female with polymorbidity and polypharmacyV. Schmidt,R. Blum,M. Möhrenschlager
J Eur Acad Dermatol Venereol. 2021 Oct 4 doi.org/10.1111/jdv.17722
Herpes zoster viral infection after AZD1222 and BNT162b2 coronavirus disease 2019 mRNA vaccines: a case seriesD. Koumaki,S.-E. Krueger-Krasagakis,M. Papadakis,A. Katoulis,V. Koumaki,G. Evangelou,M. Stefanidou,D. Mylonakis,K. Zografaki,K. Krasagakis
J Eur Acad Dermatol Venereol. 2021 Oct 4 doi.org/10.1111/jdv.17720
Pfizer/BioNTech-associated perniosis in two young adults with re-challenge evidence
S.G. Brooks,R. Alhusayen,V. Piguet,D. Croitoru
J Eur Acad Dermatol Venereol. 2021 Oct 4 doi.org/10.1111/jdv.17719
Cutaneous findings following COVID-19 vaccination: Review of world literature and own experienceThilo Gambichler,Stefanie Boms,Laura Susok,Heinrich Dickel,Cansu Finis,Nessr Abu Rached,Milan Barras,Markus Stücker,Dimitri Kasakovski
J Eur Acad Dermatol Venereol. 2021 Oct 17 doi.org/10.1111/jdv.17744
Comment on “Development of eruptive pseudoangiomatosis following COVID-19 inmunization-apropos of 5 cases”: could eruptive pseudoangiomatosis represent a paraviral eruption associated with SARS-CoV-2?Cristina Moya-Martinez,Emilio de Dios Berná-Rico,Ana Melian-Olivera,Carmen Moreno-Garcia del Real,Diego Fernández-Nieto
J Eur Acad Dermatol Venereol. 2021 Oct 17 com/doi/10.1111/jdv.17750
Generalized erythema multiforme-like skin rash following the first dose of COVID-19 vaccine (Pfizer-BioNTech)Minjae Kim,Jee Woo Kim,Minsu Kim,Sun Young Choi,Jung-Im Na
J Eur Acad Dermatol Venereol. 2021 Oct 17 com/doi/10.1111/jdv.17757
Severe necrotizing myopathy after COVID-19 vaccine with BNT162b2 and regimen with ipilimumab plus nivolumab in a patient with advanced melanomaManon Blaise,Fanny Rocher,Hélène Spittler,Adrien Sanchez,Elisabeth Lanteri,Lucia Coco,Angela Puma,Arnaud Martel,Geraldine Gonfrier,Thierry Passeron,Henri Montaudié
J Eur Acad Dermatol Venereol. 2021 Oct 17 doi.org/10.1111/jdv.17760
Cutaneous adverse reactions from 35,229 doses of Sinovac and AstraZeneca COVID-19 vaccination: A prospective cohort study in healthcare workersPawinee Rerknimitr,Thanaporn Puaratanaarunkon,Chanidapa Wongtada,Namthong Wittayabusarakam,Saran Krithin,Leilani Paitoonpong,Chanat Kumtornrut,Stephen J Kerr,Pravit Asawanonda,Watsamon Jantarabenjakul,Jettanong Klaewsongkram
J Eur Acad Dermatol Venereol. 2021 Oct 17 com/doi/10.1111/jdv.17761
Erythema nodosum following the first dose of ChAdOx1-S nCoV-19 vaccineNorma Cameli,Martina Silvestri,Maria Mariano,Luigi Bennardo,Steven Paul Nisticò,Antonio Cristaudo
J Eur Acad Dermatol Venereol. 2021 Oct 18 com/doi/10.1111/jdv.17762
Response to ‘A skin reaction with rust-like discolouration to mRNA COVID-19 vaccine
C Kouki,K Sellami,E Bahloul,M Amouri,A Masmoudi,H Turki
J Eur Acad Dermatol Venereol. 2021 Oct 17 com/doi/10.1111/jdv.17751
Regression of common viral warts after ChAdOx1-S COVID-19 vaccineAnna Płaszczyńska,Martyna Sławińska,Michał Sobjanek
J Eur Acad Dermatol Venereol. 2021 Oct 26 doi.org/10.1111/jdv.17771
Lymphomatoid drug reaction developed after BNT162b2 (Comirnaty) COVID-19 vaccine manifesting as pityriasis lichenoides et varioliformis acuta-like eruptionA. Sernicola,A. Dybala,V. Gomes,P. Maddalena,F. Adotti,G. Soda,R. Muharremi,P. Fino,E. Del Duca,T. Grieco
J Eur Acad Dermatol Venereol. 2021 Nov 9 doi.org/10.1111/jdv.17807
Eosinophilic dermatosis after AstraZeneca COVID-19 vaccinationE. Cinotti,J.-L. Perrot,F. Bruzziches,L. Tognetti,A. Batsikosta,E. Sorrentino,A.V. Marzano,P. Rubegni
J Eur Acad Dermatol Venereol. 2021 Nov 9 doi.org/10.1111/jdv.17806
Reply to “New-onset cutaneous lichen planus triggered by COVID-19 vaccination” by Merhy et al
E. Camela,G. Guerrasio,C. Patruno,M. Scalvenzi,N. Di Caprio,G. Fabbrocini,M. Napolitano
J Eur Acad Dermatol Venereol. 2021 Dec 11 doi.org/10.1111/jdv.17866
Emergence of Behçet’s disease post-SARS-CoV2-vaccination: two clinical cases in JapanH. Hashizume,S. Ajima,Y. Ishikawa
J Eur Acad Dermatol Venereol. 2021 Dec 11 doi.org/10.1111/jdv.17859
Development of pemphigus vulgaris following mRNA SARS-CoV-19 BNT162b2 vaccination in an 89-year-old patientG.V. Knechtl,S.M. Seyed Jafari,T. Berger,A. Rammlmair,L. Feldmeyer,L. Borradori
J Eur Acad Dermatol Venereol. 2021 Dec 12 doi.org/10.1111/jdv.17868
Exuberant lichenoid eruption after Oxford–AstraZeneca COVID-19 vaccine: a singular caseC. Correia,S. Fernandes,L. Soares-de-Almeida,P. Filipe
J Eur Acad Dermatol Venereol. 2021 Dec 16 doi.org/10.1111/jdv.17872
Extensive cutaneous lichen planus triggered by viral vector COVID-19 vaccination (ChAdOx1 nCoV-19)C. Masseran,A. Calugareanu,F. Caux,G. Bohelay
J Eur Acad Dermatol Venereol. 2021 Dec 21 doi.org/10.1111/jdv.17899
Lichen planus after CoronaVac: a rare complication of vaccines A. Satılmış Kaya,N. Cemşitoğlu,E. Adışen,Ö. Erdem
J Eur Acad Dermatol Venereol. 2022 Jan 6 doi.org/10.1111/jdv.17906
Bullous pemphigoid in a young male after COVID-19 mRNA vaccine: a report and brief literature reviewM. Pauluzzi,G. Stinco,E. Errichetti
J Eur Acad Dermatol Venereol. 2021 Dec 20 doi.org/10.1111/jdv.17891
Cutaneous manifestations following COVID-19 vaccination: a multicentric descriptive cohortE. Massip,P. Marcant,G. Font,S. Faiz,S. Duvert-Lehembre,I. Alcaraz,A. Vermersch-Langlin,M. Véron,C. Macaire,K. Faure,F. Vuotto,D. Staumont-Sallé,F. Dezoteux
J Eur Acad Dermatol Venereol. 2021 Dec 20 doi.org/10.1111/jdv.17883
SCLE manifestation after mRNA COVID-19 vaccinationL. Rechtien,C. Erfurt-Berge,M. Sticherling
J Eur Acad Dermatol Venereol. 2021 Dec 20 doi.org/10.1111/jdv.17895
Genital necrosis with cutaneous thrombosis after COVID-19 mRNA vaccinationA. Kuzumi,A. Yoshizaki,K. Chiba,S. Mitsuo,K.M. Matsuda,Y. Norimatsu,K. Nagai,J. Omatsu,T. Miyake,S. Sato
J Eur Acad Dermatol Venereol. 2021 Nov 28 doi.org/10.1111/jdv.17837
Koebner phenomenon with lichen planus in an area of previous vitiligo after COVID-19 vaccination and the creation of a locus minoris resistentiaeA.L. Tatu,T. Nadasdy,L.C. Nwabudike
J Eur Acad Dermatol Venereol. 2021 Dec 11 doi.org/10.1111/jdv.17864
Eosinophilic panniculitis: a new side effect of Sinopharm COVID-19 vaccineJ. Kaikati,A. Ghanem,R. El Bahtimi,J. Helou,R. Tomb
J Eur Acad Dermatol Venereol. 2022 Jan 12 doi.org/10.1111/jdv.17920
COVID vaccine-induced pustular psoriasis in patients with previous plaque type psoriasisV. Piccolo,T. Russo,C. Mazzatenta,A. Bassi,G. Argenziano,M. Cutrone,M. E. S. Danielsson Darlington,R. Grimalt
J Eur Acad Dermatol Venereol. 2022 Jan 11 doi.org/10.1111/jdv.17918
COVID vaccine-induced reaction around molluscum contagiosum with secondary partial clearance of lesions
V. Piccolo,A. Bassi,C. Mazzatenta,G. Argenziano,M. Cutrone,R. Grimalt,T. Russo
J Eur Acad Dermatol Venereol. 2022 Jan 12 doi.org/10.1111/jdv.17919
Stevens-Johnson Syndrome induced by Vaxvetria (AZD1222) Covid-19 vaccineC. Aimo,E.B. Mariotti,A. Corrà,E. Cipollini,O. Le Rose,C. Serravalle,N. Pimpinelli,M. Caproni
J Eur Acad Dermatol Venereol. 2022 Feb 08 doi.org/10.1111/jdv.17988
Pityriasis Lichenoides et Varioliformis Acuta Following COVID-19 mRNA VaccinationJ. Palmén,M. Lepistö,L. Talve,N. Hieta
J Eur Acad Dermatol Venereol. 2022 Jan 11 doi.org/10.1111/jdv.17912
Cutaneous Reactions due to Pfizer’s BNT162b2 mRNA and Moderna’s mRNA-1273 VaccinesA. Oulee,S. Salem,R. Yahia,K. Yang,D. Garcia,A. Holmes,B. Furukawa
J Eur Acad Dermatol Venereol. 2022 Jan 13 doi.org/10.1111/jdv.17925
Wells’ syndrome following Oxford–AstraZeneca COVID-19 vaccinationY. H. Kim,Y. C. Kim
J Eur Acad Dermatol Venereol. 2022 Jan 11 doi.org/10.1111/jdv.17916
Trigger of Type 2 Lepra reaction with acute foot drop following Covid-19 vaccination
A.K. Panda,F. Begum,M. Panda,A.K. Jena
J Eur Acad Dermatol Venereol. 2022 Jan 11 doi.org/10.1111/jdv.17915
Psoriasis flare-up after AZD1222 and BNT162b2 COVID-19 mRNA vaccines: report of twelve cases from a single centreD. Koumaki,S.-E. Krueger-Krasagakis,M. Papadakis,A.C. Katoulis,I. Gkiaouraki,K. Zografaki,D. Mylonakis,K. Krasagakis
J Eur Acad Dermatol Venereol. 2022 Jan 24 doi.org/10.1111/jdv.17965
Reply to “The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?” by Damiani G et al.G. Avallone,S. Giordano,C. Astrua,M. Merli,R. Senetta,C. Conforti,S. Ribero,A.V. Marzano,P. Quaglino
J Eur Acad Dermatol Venereol. 2022 Jan 23 doi.org/10.1111/jdv.17959
A first case of “Covid toes” from a viral vector-based COVID-19 vaccineA. Van Loon,D. Mortelmans,V. Siozopoulou,B. Ogunjimi,H. Jansens,J. Lambert,O. Aerts
J Eur Acad Dermatol Venereol. 2022 Jan 23 doi.org/10.1111/jdv.17948
Cutaneous arteritis following mRNA-1273 Moderna COVID-19 vaccinationT. Ogawa,U. Aitake,T. Nomura
J Eur Acad Dermatol Venereol. 2022 Jan 23 doi.org/10.1111/jdv.17947
A study of COVID-19 vaccine (Covishield) induced dermatological adverse effects from IndiaP. Das,S. Arora,G.K. Singh,P. Bellad,R. Rahman,A. Bahuguna,D. Sapra,R. Shrivastav,A. Gupta
J Eur Acad Dermatol Venereol. 2022 Jan 24 doi.org/10.1111/jdv.17951
Incident bullous pemphigoid in a psoriatic patient following mRNA-1273 SARS-CoV-2 vaccinationW.-K. Hung,C.-C. Chi
J Eur Acad Dermatol Venereol. 2022 Jan 24 doi.org/10.1111/jdv.17955
“COVID nose” – a unique post-COVID pigmentary sequelae reminiscing Chik sign: a descriptive case seriesA. Sil,A. Panigrahi,A. Chandra,J.D. Pramanik
J Eur Acad Dermatol Venereol. 2022 Feb 08 doi.org/10.1111/jdv.17989
Reply to “COVID vaccine-induced lichen planus on areas previously affected by vitiligo”E. Bularca,J. Monte-Serrano,P. Villagrasa-Boli,A. Lapeña-Casado,S. de-la-Fuente
J Eur Acad Dermatol Venereol. 2022 Feb 11 doi.org/10.1111/jdv.18001
Development of eruptive pseudoangiomatosis following immunization with COVISHIELD vaccine in an adultT. Prarthana,S. Bakshi,V. Hanumanthu,U. Nahar,D. De
J Eur Acad Dermatol Venereol. 2022 Feb 08 doi.org/10.1111/jdv.17990
Subacute cutaneous lupus erythematosus induction after SARS-CoV-2 Vaccine in a patient with primary biliary cholangitisC. Zengarini,A. Pileri,F.P. Salamone,B.M. Piraccini,G. Vitale,M. La Placa
J Eur Acad Dermatol Venereol. 2021 Nov 22 doi.org/10.1111/jdv.17827
Not only toes and fingers: COVID vaccine-induced chilblain-like lesions of the kneesA. Bassi,C. Mazzatenta,A. Sechi,M. Cutrone,V. Piccolo
J Eur Acad Dermatol Venereol. 2022 Feb 21 doi.org/10.1111/jdv.18025
A case of psoriatic spondyloarthritis exacerbation triggered by COVID-19 messenger RNA vaccineS. Ohmura,S. Hanai,R. Ishihara,Y. Ohkubo,T. Miyamoto
J Eur Acad Dermatol Venereol. 2022 Feb 17 doi.org/10.1111/jdv.18013
Unilateral linear purpuric rash heralding SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopeniaY.-T. Hung,Y.-L. Huang,Y.-Y. Chang,W.-T. Chen
J Eur Acad Dermatol Venereol. 2022 Feb 17 doi.org/10.1111/jdv.18014
Pityriasis lichenoides et varioliformis acuta after SARS-CoV-2 infection and relapse after vaccinationT. Mäkilä,L. Jeskanen,M. Butina,L. Harjama,A. Ranki,T. Mälkönen,N. Kluger
J Eur Acad Dermatol Venereol. 2022 Feb 19 doi.org/10.1111/jdv.18024
Generalized pustular psoriasis flare in a patient affected by plaque psoriasis after BNT162b2 mRNA COVID-19 vaccine, successfully treated with risankizumabG. Pavia,L. Gargiulo,F. Spinelli,J. Avagliano,M. Valenti,R. G. Borroni,A. Costanzo,A. Narcisi
J Eur Acad Dermatol Venereol. 2022 Feb 27 doi.org/10.1111/jdv.18032
Association between vaccination and immunobullous disorders: a brief, updated systematic review with focus on COVID-19M. Kasperkiewicz,D.T. Woodley
J Eur Acad Dermatol Venereol. 2022 Feb 26 doi.org/10.1111/jdv.18030
Erythema nodosum leprosum post-COVID-19 vaccination: endemic while pandemicT. Fachler,K. Olshtain-Pops,L. Horev
J Eur Acad Dermatol Venereol. 2022 Feb 28 doi.org/10.1111/jdv.18035
Pityriasis rubra pilaris (type I) following ChAdOx1 COVID-19 vaccine: A report of two cases with successful treatment with oral isotretinoinP.R. Criado,M. Ianhez,P.S. Rocha,H.A. Miot
J Eur Acad Dermatol Venereol. 2022 Mar 12 doi.org/10.1111/jdv.18055
Erythema gyratum repens after COVID vaccinationD. Chiquito,J.C.C. Xavier-Junior,G. Peres,O. Lupi
J Eur Acad Dermatol Venereol. 2022 Mar 11 doi.org/10.1111/jdv.18061
Another case of generalized bullous fixed drug eruption following an adenoviral vector-based COVID-19 vaccine (ChAdOx1 nCov-19)C. Ben Salem,A. Khelif,D. Sahnoun,N. Ghariani,B. Sriha,M. Denguezli
J Eur Acad Dermatol Venereol. 2022 Mar 11 doi.org/10.1111/jdv.18059
Case of lichen planus pigmentosus–inversus after Oxford–AstraZeneca COVID-19 vaccine: cause or coincidence?L. Sun,S. Duarte,L. Soares-de-Almeida
J Eur Acad Dermatol Venereol. 2022 Mar 12 doi.org/10.1111/jdv.18058
Two cases of anti-TIF1-γ antibody positive dermatomyositis with manifested symptoms after SARS-CoV-19 vaccination
A. Yoshida,T. Ikegami,K. Igawa
J Eur Acad Dermatol Venereol. 2022 Mar 11 doi.org/10.1111/jdv.18060
Erythema multiforme in COVID-19 patients and following COVID-19 vaccination: manifestations, associations and outcomesF. Etaee,M. Eftekharian,T. Naguib,S. Daveluy
J Eur Acad Dermatol Venereol. 2022 Mar 11 doi.org/10.1111/jdv.18063
Symmetrical drug-related intertriginous and flexural exanthema-like eruption after COVID-19 vaccine
I. Lahouel,N. Ben Salah,N. Ben Fadhel,F. Chahed,N. Ouni,H. Belhadjali,K. Aouem,J. Zili
J Eur Acad Dermatol Venereol. 2022 Mar 28 doi.org/10.1111/jdv.18108
Transient inflammation in surgical scars following Covid-19 mRNA vaccinationC. Ferreli,J. Anedda,L. Atzori
J Eur Acad Dermatol Venereol. 2022 Mar 19 doi.org/10.1111/jdv.18088
De novo annular pustular psoriasis following mRNA COVID-19 vaccineM. Romagnuolo,P. Pontini,S. Muratori,A. V. Marzano,C. Moltrasio
J Eur Acad Dermatol Venereol. 2022 Mar 29 doi.org/10.1111/jdv.18114
Commentary on ‘Psoriasis flare-up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine’D. Turkmen,N. Altunisik
J Eur Acad Dermatol Venereol. 2022 Mar 30 doi.org/10.1111/jdv.18117
Rare cutaneous reactions after ChAdOx1 (Oxford-AstraZeneca) vaccine: 12 case series from BrazilC.A. Seque,M.M.S.S. Enokihara,M.M. Nascimento,A.M. Porro,J. Tomimori
J Eur Acad Dermatol Venereol. 2022 Mar 29 doi.org/10.1111/jdv.18112
Haemorrhagic bullous pyoderma gangrenosum following COVID-19 vaccinationY.-T. Hung,W.-H. Chung,T.-F. Tsai,C.-B. Chen
J Eur Acad Dermatol Venereol. 2022 Apr 10 doi.org/10.1111/jdv.18132
Two cases of axillary lymphadenopathy diagnosed as diffuse large B-cell lymphoma developed shortly after BNT162b2 COVID-19 vaccinationM. Mizutani,H. Mitsui,T. Amano,Y. Ogawa,N. Deguchi,S. Shimada,A. Miwa,T. Kawamura,Y. Ogido
J Eur Acad Dermatol Venereol. 2022 Apr 10 doi.org/10.1111/jdv.18136
SARS-CoV-2 mRNA booster vaccine-associated lichenoid drug eruptionD. Mintoff,D. Pisani,N. Livori,I. Said-Huntingford,G. Baldacchino
J Eur Acad Dermatol Venereol. 2022 Apr 16 doi.org/10.1111/jdv.18149
Cutaneous adverse effects of the available COVID-19 vaccines in India: a questionnaire-based studyJ. Bawane,R. Kataria,A. Mohite,K. Verma,U. Shukla
J Eur Acad Dermatol Venereol. 2022 Apr 16 doi.org/10.1111/jdv.18150
Sweet Syndrome following SARS-CoV-2 CoronaVac vaccine
N. Ben Salah,M. Korbi,N. Ben Fadhel,I. Safa,F. Chad,M. Njima,H. Belhadjali,M. Amri,K. Aouam,J. Zili
J Eur Acad Dermatol Venereol. 2022 June 20 doi.org/10.1111/jdv.18336
Safe administration of subsequent mRNA COVID-19 vaccine doses following a possible allergic reaction to the first dose
M.S. Roth,S. Chantraine,C.A. Morales Mateluna,K. Hartmann,C.T. Berger
J Eur Acad Dermatol Venereol. 2022 June 30 doi.org/10.1111/jdv.18387
Generalized and persistent skin pigmentation after COVID-19 vaccination
J. Lu,Y. Liu,Y. Sun
J Eur Acad Dermatol Venereol. 2022 June 30 doi.org/10.1111/jdv.18379
Influence of Covid-19 vaccination on immune-mediated skin diseases
N. A. Alelq,M. E. Kubieniec,L. E French,J. C. Prinz
J Eur Acad Dermatol Venereol. 2022 June 30 doi.org/10.1111/jdv.18388
Pyoderma gangrenosum after mRNA-based SARS-CoV-2 vaccineJ. Franceschi,A.S. Darrigade,P. Sanchez-Pena,V. Legrain-Lifermann,B. Milpied
J Eur Acad Dermatol Venereol. 2022 June 30 doi.org/10.1111/jdv.18389
Pityriasis lichenoides chronica after BNT162b2 Pfizer-BioNTech vaccine: A novel cutaneous reaction after SARS-CoV-2 vaccine
F. Drago,G. Ciccarese,A. Guadagno,A. Parodi
J Eur Acad Dermatol Venereol. 2022 July 16 doi.org/10.1111/jdv.18418
A severe case of papulovesicular exthanthema with rhabdomyolysis after corona virus disease 2019 heterologous booster vaccination
A. Baba,Y. Maki,T. Kanekura,H. Tsubouchi
J Eur Acad Dermatol Venereol. 2022 July 16 doi.org/10.1111/jdv.18420
Bullous pemphigoid and COVID-19 vaccination: Management and treatment reply to ‘Bullous pemphigoid in a young male after COVID-19 mRNA vaccine: A report and brief literature review’ by Pauluzzi et al.
Fabrizio Martora,Angelo Ruggiero,Teresa Battista,Gabriella Fabbrocini,Matteo Megna
J Eur Acad Dermatol Venereol. 2022 August 16 doi.org/10.1111/jdv.18503
Alopecia areata after COVID-19 infection and vaccination: A cross-sectional analysis
Betty Nguyen,Antonella Tosti
J Eur Acad Dermatol Venereol. 2022 August 11 doi.org/10.1111/jdv.18491
New-onset vitiligo after COVID-19 mRNA vaccination: A causal association?
Electra Nicolaidou,Charitomeni Vavouli,Ioannis-Alexios Koumprentziotis,Maria Gerochristou,Alexander Stratigos
J Eur Acad Dermatol Venereol. 2022 August 16 doi.org/10.1111/jdv.18513
Association of interstitial granulomatous dermatitis with messenger Rna–1273 Sars-Cov-2 vaccine
Cesare Ariasi,Gabriele Perazzolli,Alessandra Gelmetti,Simonetta Battocchio,Piergiacomo Calzavara-Pinton
J Eur Acad Dermatol Venereol. 2022 August 14 doi.org/10.1111/jdv.18490
New onset pemphigus foliaceus following AstraZeneca COVID-19 vaccination
Mina Almasi-Nasrabadi,Radha S. Ayyalaraju,Ashish Sharma,Somaia Elsheikh,Shanti Ayob
J Eur Acad Dermatol Venereol. 2022 August 14 doi.org/10.1111/jdv.18484
Skin reaction after SARS-CoV-2 vaccines Reply to ‘cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: A real-life multicentre experience’
Fabrizio Martora,Alessia Villani,Claudio Marasca,Gabriella Fabbrocini,Luca Potestio
J Eur Acad Dermatol Venereol. 2022 August 16 doi.org/10.1111/jdv.18531
Reply to ‘Nail psoriasis: A rare mRNA COVID-19 vaccine reaction’ by Lamberti A et al.
Angelo Ruggiero,Luca Potestio,Teresa Battista,Gabriella Fabbrocini,Matteo Megna
J Eur Acad Dermatol Venereol. 2022 August 22 doi.org/10.1111/jdv.18537
Real-world data on primary cutaneous lymphoproliferative disorders following SARS-CoV-2 vaccination: A multicentre experience from tertiary referral hospitals
Gianluca Avallone, Carlo Alberto Maronese, Claudio Conforti, Paolo Fava, Luigi Gargiulo, Angelo Valerio Marzano, Cesare Massone, Luca Mastorino, Andrea Paradisi, Alessandro Pileri, Pietro Quaglino, Nathalie Rizzo, Simone Ribero, Gabriele Roccuzzo, Gianluca Tavoletti, Carlo Alberto Vignoli, Iris Zalaudek, Emilio Berti, Silvia Alberti-Violetti
J Eur Acad Dermatol Venereol. 2022 December 05 doi.org/10.1111/jdv.18806
Epidermal necrolysis after COVID−19 vaccination: An exploratory analysis using World Health Organization VigiBase
Btisseme Ahouach, Emmanuelle Diaz, Blandine Bertin, Benoit Ben Said, Sandrine Combret, Aurélie Grandvuillemin, Nadine Petitpain, Marie Blanche Rabier, Laure Thomas, Thierry Trenque, Saskia Ingen-Housz-Oro, Bénédicte Lebrun-Vignes
J Eur Acad Dermatol Venereol. 2023 January 06 doi.org/10.1111/jdv.18845
Reply to: ‘Severe bullous pemphigoid following Covid-19 vaccination resistant to rituximab and successfully treated with dupilumab’ by Baffa et al.
L. Sun, C. Brazão, D. Mancha, L. Soares-de-Almeida, P. Filipe
J Eur Acad Dermatol Venereol. 22 January 2023 doi.org/10.1111/jdv.18893
Risk–benefit profiles associated with receiving Moderna COVID-19 (mRNA-1273) vaccine as an additional pre-booster dose in immune-mediated dermatologic disease patients with low SARS-CoV-2-specific immunity following the primary series: A prospective cohort study
C. Seree-aphinan, P. Suchonwanit, P. Rattanakaemakorn, C. Pomsoong, Y. Ratanapokasatit, C. Setthaudom, T. Suangtamai, K. Chanprapaph, the COVIDVAC-DERM study group
J Eur Acad Dermatol Venereol. 20 January 2023 doi.org/10.1111/jdv.18890
Clinical and immunological impact of booster immunization with recombinant mRNA vaccines for SARS-CoV-2 in patients with pemphigus and bullous pemphigoid
F. Solimani, A. Mesas-Fernández, E. Bodner, M. Carevic-Neri, M. Hasheminasab, T. Jakovljevicova, A. Philipp, A. Nast, M. Worm, F. J. Hilke, K. Meier, K. Ghoreschi
J Eur Acad Dermatol Venereol. 14 February 2023 doi.org/10.1111/jdv.18967
Increasing the COVID-19 immunization rate through allergy testing
R. K. Bent, J. Weinbrenner, V. Faihs, S. Steffens, T. Nau, M. Vitus, S. Mathes, U. Darsow, T. Biedermann, K. Brockow
J Eur Acad Dermatol Venereol. 18 February 2023 doi.org/10.1111/jdv.18979
Generalized painful papulovesicular eruption following the COVID-19 BNT162b2 mRNA vaccine
J. M. Lee, Y. S. Lee, Y. J. Lee, J. H. Lee, T. Y. Han, J. E. Choi
J Eur Acad Dermatol Venereol. 13 March 2023 doi.org/10.1111/jdv.19043
Stevens-Johnson Syndrome-Toxic Epidermal Necrolysis Overlap Case Possibly Induced by COVID-19 Vaccine
Hülya Cenk, Mahmut Anıl Karataş, Niyazi Çetin, Erdem Çomut, Şule Gökşin, Özge Sevil Karstarlı Bakay, Nida Kaçar
J Eur Acad Dermatol Venereol. 28 March 2023 doi.org/10.1111/jdv.19065
Erythema multiforme major associated with molnupiravir treatment for SARS-CoV-2 infection: first report
Corrado Zengarini, Vito Epifani, Carlotta Baraldi, Martina Mussi, Luciano Potena, Laura Giovannini, Alessandro Pileri
J Eur Acad Dermatol Venereol. 05 April 2023 doi.org/10.1111/jdv.19099
VEXAS syndrome following COVID-19 mRNA vaccination
François Skowron, Lucas Klepfisch, Laurent Guillaume, Janique Godeneche, Anthony Facile, Martin Gombert, Suzann Pechuzal, Jean-Luc Perrot
J Eur Acad Dermatol Venereol. 05 April 2023 doi.org/10.1111/jdv.19104
A case of erythema elevatum diutinum after COVID-19 vaccination
Bushra Muna
J Eur Acad Dermatol Venereol. 12 May 2023 doi.org/10.1111/jdv.19188
A case of recurrence of pyoderma gangrenosum after Covid-19 vaccine
L. Bettolini, S. Bighetti, S. Mezzana, A. Gelmetti, P. Calzavara-Pinton, V. Maione
J Eur Acad Dermatol Venereol. 20 June 2023 doi.org/10.1111/jdv.19285
S. Petti, P. G. Arduino
J Eur Acad Dermatol Venereol. 16 June 2023 doi.org/10.1111/jdv.19271
K. Kanabaj, M. Sokołowska-Wojdyło, A. Wilkowska, R. J. Nowicki
J Eur Acad Dermatol Venereol. 06 July 2023 doi.org/10.1111/jdv.19305
Ulcerating Reaction in Association with Pfizer-BioNTech COVID-19 Vaccine in an 11-Year-Old Boy
Justin Thrush, Samantha Polly, John Anthony, James Fernandez, James Taylor, DeVon C. Preston, Anthony P. Fernandez
J Eur Acad Dermatol Venereol. 23 August 2023 doi.org/10.1111/jdv.19460
Raquel Falcão de Freitas, António Freitas
J Eur Acad Dermatol Venereol. 18 August 2023 doi.org/10.1111/jdv.19444
Ayaka Itami, Tomomitsu Miyagaki, Shuhei Mitsuishi, Akihiro Horie, Tatsuro Okano, Sora Takeuchi, Takayasu Ando, Takafumi Kadono
J Eur Acad Dermatol Venereol. 10 August 2023 doi.org/10.1111/jdv.19401
A severe relapse of Pemphigus Vulgaris after SARS-CoV-2 vaccination.
L. Ligrone, S. Lembo, F. Cillo, S. Spennato, G. Fabbrocini, A. Raimondo
J Eur Acad Dermatol Venereol. 10 August 2023 doi.org/10.1111/jdv.19414
Occupational skin disease, including effects of PPE
Dermatology staff participate in fight against Covid-19 in ChinaZheng Y, Lai W
J Eur Acad Dermatol Venereol. 2020 Mar 23. doi: 10.1111/jdv.16390
Skin reactions to non-glove personal protective equipment: An emerging issue in the COVID-19 pandemicGheisari M, Araghi F, Moravvej H, Tabary M, Dadkhahfar S
J Eur Acad Dermatol Venereol. 2020 Apr 17. doi: 10.1111/jdv.16492
Covid-19: Countermeasure for N95 mask-induced pressure soreYin Z.
J Eur Acad Dermatol Venereol. 2020 Apr 17. doi: 10.1111/jdv.16490
Hand disinfection in the combat against Covid-19Goldust M, Abdelmaksoud A, Navarini AA
J Eur Acad Dermatol Venereol. 2020 May 3. doi: 10.1111/jdv.16574
COVID-19 epidemic: Skin protection for health care workers must not be ignoredZhang B, Zhai R, Ma L.
J Eur Acad Dermatol Venereol. 2020 May 2. doi: 10.1111/jdv.16573
Occupational skin conditions on the frontline: A survey among 484 Chinese healthcare professionals caring for Covid-19 patientsPei S, Xue Y, Zhao S, Alexander N, Mohamad G, Chen X, Yin M
J Eur Acad Dermatol Venereol. 2020 May 3. doi: 10.1111/jdv.16570
Localised mid-face miliaria as a consequence of filtering face piece (FFP) respirator use during the COVID-19 pandemicCampbell V, Middleton D, Donnelly J, Hunter H
J Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16624
Personal protective equipment induced facial dermatoses in healthcare workers managing COVID-19 casesSingh M, Pawar M, Bothra A, Maheshwari A, Dubey V, Tiwari A, Kelati A
J Eur Acad Dermatol Venereol. 2020 May 12. doi: 10.1111/jdv.16628
Efficacy of hydrogel patches in preventing facial skin damage caused by mask compression in fighting against coronavirus disease-2019: a short-term, self-controlled studyDong L, Yang L, Li Y, Yang J, An X, Yang L, Zhou N, Zhang Y, Du H, Lan J, Song Z, Miao X, Zhu J, Tao J
J Eur Acad Dermatol Venereol. 2020 May 18. doi: 10.1111/jdv.16638
Protecting medical staff from skin injury/disease caused by personal protective equipments during epidemic period of COVID-19: experience from ChinaH. Long, H. Zhao, Z. Yao, B. Cheng, Q. Lu
J Eur Acad Dermatol Venereol 2020; May 22 doi.org/10.1111/jdv.16388
Hand Eczema Pandemic Caused by COVID-19 Hygiene Measures: The Setup of a Hand Eczema Helpline for Hospital PersonnelK. Greveling, A.C.M. Kunkeler
J Eur Acad Dermatol Venereol 2020 June 2 doi.org/10.1111/jdv.16695
Retroauricular dermatitis with vehement use of ear loop face masks during COVID‐19 pandemicBothra A, Das S, Singh M, Pawar M, Maheswari A
J Eur Acad Dermatol Venereol. 2020 Jun 3. doi: 10.1111/jdv.16692
Occupational skin disease during the COVID-19 pandemic, as captured in a Dermatology staff clinic in the United KingdomHadjieconomou S, Hughes J, Kamath S
J Eur Acad Dermatol Venereol. 2020 Jun 14. doi: 10.1111/jdv.16754
Symmetric chest pressure ulcers, consequence of prone position ventilation in a patient with COVID-19Martínez Campayo N, Bugallo Sanz JI, Mosquera Fajardo I
J Eur Acad Dermatol Venereol. 2020 Jun 15. doi: 10.1111/jdv.16755
How the use of surgical masks during COVID-19 pandemic can induce skin effectsVeronese S, Bernardi P, Sbarbati A
J Eur Acad Dermatol Venereol. 2020 Sep 1. doi: 10.1111/jdv.16905
Occupational dermatoses from PPE during the COVID-19 pandemic in the tropics – A reviewLee HC, Goh CL
J Eur Acad Dermatol Venereol. 2020 Sep 7. doi: 10.1111/jdv.16925
Adverse skin reactions following different types of mask usage during the COVID-19 pandemicC. Chaiyabutr T. Sukakul C. Pruksaeakanan J. Thumrongtharadol W. Boonchai
J Eur Acad Dermatol Venereol. 2020 Nov 21 doi.org/10.1111/jdv.17039
Adverse skin reactions related to PPE among health care workers managing Covid-19Priyanka Sharma Nainika Goel Kanika Dogar Mala Bhalla GP Thami Kavita Punia
J Eur Acad Dermatol Venereol. 2021 Apr 18 doi.org/10.1111/jdv.17290
Adverse Skin Reactions Due to Use of Face Masks: A Prospective Survey during the COVID-19 Pandemic in KoreaS.J. Park, H.S. Han, S.H. Shin, K.H. Yoo, K. Li, B.J. Kim, S.J. Seo, K.Y. Park
J Eur Acad Dermatol Venereol. 2021 Jun 15 com/doi/10.1111/jdv.17447
Dermatoses caused by face mask wearing during the COVID-19 pandemicO.Yu. Olisova, N.P. Teplyuk, E.V. Grekova, A.A. Lepekhova
J Eur Acad Dermatol Venereol. 2021 Jul 26 oi/full/10.1111/jdv.17546
Characteristics of facial skin problems and microbiome variation during wearing masks for fighting against COVID-19C. Huang, Q. Sun, D. Jiang, X. Zhang, C. Chen, D. Yan, X. Liu, Y. Zhou, C. Ding, L. Lan, J. Wu, L. Li, A. Li, X. Liu, S. Yang
J Eur Acad Dermatol Venereol. 2021 Aug 7 oi/full/10.1111/jdv.17580
Personal protective equipment use and face acne in health care providers during the COVID-19 pandemic in Romania: a new occupational acne type?S Cretu,M Dascalu,SR Georgescu,CM Salavastru
J Eur Acad Dermatol Venereol. 2021 Sep 21 com/doi/10.1111/jdv.17679
Reply to “Dermatoses caused by face mask wearing during the COVID-19 pandemic”F. Bardazzi,L. Sacchelli,C. Loi,F. Filippi,A. Guglielmo
J Eur Acad Dermatol Venereol. 2022 Feb 17 doi.org/10.1111/jdv.18012
Maskne prevalence and associated factors in Irish healthcare workers during the COVID-19 pandemic
L.F. Kiely,C. O’Connor,G. O’Briain,C. O’Briain,J. Gallagher,J.F. Bourke
J Eur Acad Dermatol Venereol. 2022 Mar 12 doi.org/10.1111/jdv.18054
Disseminated herpes zoster in an immune-competent patient after SARS-CoV-2 vaccine (BNT162b2 Comirnaty, Pfizer)
C. Zengarini,C. Misciali,T. Ferrari,E. Dika,M. La Placa,B.M. Piraccini,C. Baraldi
J Eur Acad Dermatol Venereol. 2022 Apr 16 doi.org/10.1111/jdv.16925
Education
Medical education and care in dermatology during the SARS-CoV2 pandemia: challenges and chancesReinholz M, French LE.
J Eur Acad Dermatol Venereol. 2020 Mar 27. doi: 10.1111/jdv.16391
Dermatologic Surgery Training During the COVID-19 EraGarcía-Lozano JA, Cuellar-Barboza A, Garza-Rodríguez V, Vázquez-Martínez O, Ocampo-Candiani JJ Eur Acad Dermatol Venereol. 2020 May 9. doi: 10.1111/jdv.16621
Negative SARS-CoV-2 antibodies in patients with positive immunohistochemistry for spike protein in pityriasis rosea-like eruptionsE. Welsh,J.A. Cardenas-de la Garza,E. Brussolo-Marroquín,A. Cuellar-Barboza,R. Franco-Marquez,G. Ramos-Montañez
J Eur Acad Dermatol Venereol. 2022 Apr 26 doi.org/10.1111/jdv.16391
Onset of amyopathic dermatomyositis following mRNA-based SARS-CoV-2 vaccinationA. Kreuter,S. Lausch,S.-N. Burmann,A. Paschos,A.-L. Michalowitz
J Eur Acad Dermatol Venereol. 2022 May 10 doi.org/10.1111/jdv.16621
Psycho-social implications
Mass quarantine measures in the time of COVID-19 pandemic: psycho-social implications for chronic skin conditions and a call for qualitative studiesGarcovich S, Bersani FS, Chiricozzi A, De Simone C
J Eur Acad Dermatol Venereol. 2020 Apr 24. doi: 10.1111/jdv.16535
Role of the International Pemphigus and Pemphigoid Foundation during the COVID-19 pandemicM. Kasperkiewicz,R. Strong,M. Yale,P. Dunn,D.T. Woodley
J Eur Acad Dermatol Venereol. 2022 Apr 25 doi.org/10.1111/jdv.16535
Impact of COVID-19 pandemic on acute dermatology referrals in a secondary and tertiary care Central London hospital. A retrospective comparison review of pre-COVID-19 era and COVID-19 pandemicEvangelia Panagou, Evdoxia Panou, Jennifer Crawley, Ophelia Veraitch, Emma V. Edmonds, Chris B. Bunker, Claire L. Martyn-Simmons
J Eur Acad Dermatol Venereol. 24 February 2023 doi.org/10.1111/jdv.18997
The impact of the COVID-19 pandemic on the diagnosis of cutaneous melanomas: A retrospective cohort study from five European skin cancer reference centresAlexander Troesch, Magdalena Hoellwerth, Stephan Forchhammer, Laura Del Regno, Georg Lodde, Patrick Turko, Phil F. Cheng, Mitchell L. Levesque, Eva Hadaschik, Elisabeth Livingstone, Ketty Peris, Lukas Flatz, Peter Koelblinger, Reinhard Dummer, Florentia Dimitriou
J Eur Acad Dermatol Venereol. 14 February 2023 doi.org/10.1111/jdv.18953
Delay in the diagnosis and management of suspicious malignant skin lesions during the COVID-19 pandemic in a reference center in MexicoEduardo Corona-Rodarte, Antonio Olivas-Martinez, Rodrigo Solis-Pompa, Luis Enrique Cano-Aguilar, Daniel Asz-Sigall, María del Rocío Ferrusco-Ontiveros, José Alfredo Soto-Ortiz, Liliana Burgos-Mora
J Eur Acad Dermatol Venereol. 05 April 2023 doi.org/10.1111/jdv.19109
Sexual health
SARS-CoV-2 possible contamination of genital area: implications for sexual and vertical transmission routesDelfino M, Guida M, Patrì A, Spirito L, Gallo L, Fabbrocini G
J Eur Acad Dermatol Venereol. 2020 May 7. doi: 10.1111/jdv.16591
Sexually Transmitted Infections during the COVID-19 outbreak: comparison of patients referring to the service of sexually transmitted diseases during the sanitary emergency with those referring during the common practiceSacchelli L, Viviani F, Orioni G, Rucci P, Rosa S, Lanzoni A, Patrizi A, Gaspari V.
J Eur Acad Dermatol Venereol. 2020 Jun 3. doi: 10.1111/jdv.16694
STIs and the COVID-19 pandemic: the lockdown does not stop sexual infectionsBalestri R, Magnano M, Rizzoli L, Infusino SD, Urbani F, Rech G
J Eur Acad Dermatol Venereol. 2020 Jul 11. doi: 10.1111/jdv.16808
Evolution of notified sexual transmitted infections in Barcelona during the First Wave of the COVID-19 Pandemic
G. Martin-Ezquerra, P. Monreal, L. Mercuriali, E. Cañas-Ruano, R.M. Pujol, X. Duran, M. Masferrer Niubò, P. Domingo, J. Villar-Garcia, J. Lopez-Contreras, A. Gonzalez-Cordón, P. Garcia-Olalla, M.-J. Barberá, STI-HIV group of Barcelona
J Eur Acad Dermatol Venereol. 2021 Jun 19 oi/full/10.1111/jdv.17460
Real-world evidence from over one million COVID-19 vaccinations is consistent with reactivation of the varicella-zoster virusM. Hertel,M. Heiland,S. Nahles,M. von Laffert,C. Mura,P.E. Bourne,R. Preissner,S. Preissner
J Eur Acad Dermatol Venereol. 2022 Apr 26 doi.org/10.1111/jdv.16591
Effects of wearing personal protective equipment during COVID-19 pandemic on composition and diversity of skin bacteria and fungi of medical workersX. Lin,Y.Z. Li,T. Chen,S.H. Min,D.F. Wang,M.M. Ding,G. Jiang
J Eur Acad Dermatol Venereol. 2022 May 10 doi.org/10.1111/jdv.16694
Impact of the Covid-19 pandemic on melanoma and non-melanoma skin cancer inpatient treatment in Germany – a nationwide analysisJ. Kleemann,M. Meissner,D. Özistanbullu,Ü. Balaban,O. Old,S. Kippenberger,J. Kloka,R. Kaufmann,K. Zacharowski,B. Friedrichson
J Eur Acad Dermatol Venereol. 2022 May 15 doi.org/10.1111/jdv.16808
Humoral and cellular immune responses to repeated SARS-CoV-2 infection and vaccination in an individual living with HIVAgit Simsek, Clara Bessen, Toni L Meister, Doris Urlaub, Adriane Skaletz-Rorowski, Norbert H Brockmeyer, Oliver Overheu, Anke Reinacher-Schick, Simon Faissner, Carsten Watzl, Stephanie Pfaender, Ingo Schmitz, Anja Potthoff, Carlos Plaza-Sirvent
J Eur Acad Dermatol Venereol. 13 March 2023 doi.org/10.1111/jdv.19036
Specific diseases and patient groups
Teledermatology
Healthcare and safety of patients with melanoma during the COVID-19 Pandemic in Italy
S. Caini,M. Brusasco,G. Niero,V. De Giorgi,M. Lombardo,C. Massone,M. Medri,G. Palmieri,M.A. Pizzichetta,P. Quaglino,R. Satta,C. Feliciani,S. Gandini,I. Stanganelli,Italian Melanoma Intergroup (IMI), Italian Association of Melanoma Patients (AIMaMe)
J Eur Acad Dermatol Venereol. 2022 Mar 12 doi.org/10.1111/jdv.18056
Skin cancer and COVID-19: was the diagnosis safeguarded by teledermatology? a study on 1229 casesC. Skayem,C. Hua,O. Zehou,A. Jannic, A. Viarnaud,P. Wolkenstein,T.A. Duong
J Eur Acad Dermatol Venereol. 2022 Apr 20 doi.org/10.1111/jdv.16905
Impact of SARS-CoV-2 infection in children with psoriasis: Results of a monocentric experienceFrancesca Caroppo, Laura Fagotto, Jacopo Tartaglia, Roberto Mazzetto, Anna Belloni Fortina
J Eur Acad Dermatol Venereol. 17 January 2023 doi.org/10.1111/jdv.18874
Further Reading
JEADV – Covid 19 Special Forum
WHO – Public advice, country and technical guidance, updates on Coronavirus disease
CDC – Precautions and guidance during COVID-19
American Academy of Dermatology – Coronavirus Resource Center: Resources to help protect patients and practice
British Association of Dermatologists – Statement on the management of higher risk dermatology patients during COVID-19
Academia Española de Dermatología y Venereología – Dermatologists advice, technical guidance, updates on Coronavirus disease
Société Française de Dermatologie – COVID-19 Advice from the French Society of Dermatology
Italian Society of Dermatology – The SIDeMaST Vademecum: How to behave in the Coronavirus emergency
Royal Belgian Society for Dermatology and Venereology – Dermanet: The latest information on the COVID-19
Deutsche Dermatologische Gesellschaft– COVID-19 Advice from the German Dermatological Society
Finnish Institute for Health and Welfare – THL Network for prevention and control of infectious diseases
International League of Dermatological societies – Guidance on the practice of dermato surgery and cosmetic procedures, and the use of systemic therapy for patients with psoriasis/atopic dermatitis during coronavirus outbreak.
European society for medical oncology – ESMO Statements: Helping oncology professionals deliver optimal care to their cancer patients
European League Against Rheumatism – EULAR guidance and useful resources on management of patients with Rheumatic Musculoskeletal diseases (RMDs) to provide the best possible care during the pandemic COVID-19
Filière de santé des maladies auto immunes et auto-inflammatoires rares – Management of patients with auto immune or inflammatory diseases during COVID-19
European reference Networks/Orphanet rare diseases – Recommendations and services concerning COVID-19 and rare diseases
Agence nationale de sécurité du médicament et des produits de santé – Management of dermatology patients enrolled in ongoing clinical trials during COVID-19 – English version of the French recommendations
The German Psoriasis-Registry – Recommendations for systemic therapy in people with psoriasis during the pandemic phase of SARS-CoV-2
International Psoriasis Council – Statement on the Coronavirus Outbreak
British Association for Sexual Health and HIV, in collaboration with NHS – Useful resources for the European situation on social distancing and provision of sexual services to the community
Robert Koch Institute – Information, articles and material from the Robert Koch Institut, Berlin
International prospective register of systematic reviews – Fast-tracking registration of protocols related to COVID-19 (for systematic, rapid and umbrella reviews).
MedRxiv and BioRxiv – COVID-19 SARS-CoV-2 preprints from MedRxiv and BioRxiv.
Cochrane COVID-19 Study Register – Coronavirus (COVID-19) – Cochrane resources and news.
Internationa Clinical Trials Registries – Database of privately and publicly funded clinical studies conducted around the world.
Lit Covid – Literature hub for tracking up-to-date scientific information about the 2019 novel Coronavirus.
TRIP Database – Evidence-based search engine to help health professionals find trustworthy answers to their COVID clinical questions.
Epistemonikos – Evidence-based answers for the most frequent questions regarding the COVID emergency.
Only trust information from our official website: eadv.org | Copyright 2023 EADV